These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10875847)

  • 1. Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone.
    Romàn E; Aytoz A; Smitz JE; Faguer B; Camus M; Van Steirteghem AC; Devroey P
    Hum Reprod; 2000 Jul; 15(7):1435-9. PubMed ID: 10875847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding patterns in women using intramuscular progesterone for luteal support in in-vitro fertilisation cycles.
    Gürbüz B; Yalti S; Fiçicioglu C; Delikara N; Alpay Z
    J Obstet Gynaecol; 2003 May; 23(3):267-70. PubMed ID: 12850858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles.
    Gorkemli H; Ak D; Akyurek C; Aktan M; Duman S
    Gynecol Obstet Invest; 2004; 58(3):140-4. PubMed ID: 15205566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C; Lindenberg S;
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study.
    Çakar E; Tasan HA; Kumru P; Cogendez E; Usal NT; Kutlu HT; Özkaya E; Eser SK
    J Obstet Gynaecol; 2020 Feb; 40(2):264-269. PubMed ID: 31455122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH; Hogerzeil HV; Mol BW
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.
    Claman P; Domingo M; Leader A
    Hum Reprod; 1992 Apr; 7(4):487-9. PubMed ID: 1522190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization.
    Baker VL; Jones CA; Doody K; Foulk R; Yee B; Adamson GD; Cometti B; DeVane G; Hubert G; Trevisan S; Hoehler F; Jones C; Soules M
    Hum Reprod; 2014 Oct; 29(10):2212-20. PubMed ID: 25100106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.
    Aboulghar MA; Marie H; Amin YM; Aboulghar MM; Nasr A; Serour GI; Mansour RT
    Reprod Biomed Online; 2015 Jan; 30(1):52-6. PubMed ID: 25456166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
    Tournaye H; Sukhikh GT; Kahler E; Griesinger G
    Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone vaginal capsule versus vaginal gel for luteal support in normoresponder women undergoing long agonist IVF/ICSI cycles.
    Gün İ; Özdamar Ö; Şahin S; Çetingöz E; Sofuoğlu K
    Ginekol Pol; 2016; 87(5):372-7. PubMed ID: 27304654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers.
    Wang LJ; Huang FJ; Kung FT; Lin PY; Chang SY; Lan KC
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):375-9. PubMed ID: 20045758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal phase progesterone supplementation following induced natural cycle frozen embryo transfer: A retrospective cohort study.
    Schwartz E; Bernard L; Ohl J; Bettahar K; Rongières C; Lichtblau I; Pirrello O
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):95-98. PubMed ID: 30347257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
    Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
    JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration.
    Friedler S; Raziel A; Schachter M; Strassburger D; Bukovsky I; Ron-El R
    Hum Reprod; 1999 Aug; 14(8):1944-8. PubMed ID: 10438404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.